Althea Group (AGH) Stock Price, News & Analysis

Company Overview

Althea Group Holdings Limited manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland. It also offers a range of education, access, and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways. In addition, the company provides formulation and manufacturing of recreational cannabis products, such as beverages, edibles, concentrates, and topicals; and owns and operates a private medical cannabis clinic network under the MyAccess Clinics name. Althea Group Holdings Limited was founded in 2016 and is based in Melbourne, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 454,046 shs
• Average Volume: N/A
• Market Capitalization: A$10.16 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AGH Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Althea Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Althea Group investors own include South32 (SOUHY), Curaleaf (CURLF), Clean TeQ (CLQ), 5G Networks (5GN), Village Roadshow Limited (VRL.AX) (VRL), Virgin Australia Holdings Limited (VAH.AX) (VAH) and TubeMogul (TUBE).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Transportation
• Current Symbol: ASX:AGH
• CIK: N/A
• Web: www.althea.com.au
• Phone: 1300 70 20 20
• Fax: N/A
• Employees: 5,320
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.09)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$32.06 million
• Net Margins: -109.03%
• Pretax Margin: N/A
• Return on Equity: -414.04%
• Return on Assets: -18.64%

Debt

• Debt-to-Equity Ratio: 2,082.48
• Current Ratio: 0.64
• Quick Ratio: 1.28

Sales & Book Value

• Annual Sales: A$30.36 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 4.38
• Book Value: A$0.00 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 406,500,000
• Free Float: N/A
• Market Cap: A$10.16 million
• Optionable: Not Optionable
• Beta: 1.45